These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2278054)

  • 1. Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1990; 84(5):618-21. PubMed ID: 2278054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.
    Jennings FW
    Trop Med Parasitol; 1991 Sep; 42(3):157-60. PubMed ID: 1801135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
    Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
    Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of CNS trypanosomiasis.
    Jennings FW
    Acta Trop; 1993 Sep; 54(3-4):205-13. PubMed ID: 7902658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous system involvement.
    Jennings FW; Urquhart GM; Murray PK; Miller BM
    Trans R Soc Trop Med Hyg; 1983; 77(5):693-8. PubMed ID: 6659049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei.
    Demey F
    Vet Res Commun; 1987; 11(3):271-4. PubMed ID: 2442883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies.
    Jennings FW; Hunter CA; Kennedy PG; Murray M
    Trans R Soc Trop Med Hyg; 1993; 87(2):224-6. PubMed ID: 8337735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megazol combined with suramin improves a new diagnosis index of the early meningo-encephalitic phase of experimental African trypanosomiasis.
    Darsaud A; Chevrier C; Bourdon L; Dumas M; Buguet A; Bouteille B
    Trop Med Int Health; 2004 Jan; 9(1):83-91. PubMed ID: 14728611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic and curative action of Ridzol-S and Ronidazole in experimental trypanosomiasis caused by Trypanosoma brucei et T. evansi].
    Tchalim TK
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):263-70. PubMed ID: 7195691
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis.
    Jennings FW; Ulrich P; Cerami A
    Trop Med Parasitol; 1987 Sep; 38(3):181-6. PubMed ID: 3124253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):135-8. PubMed ID: 1654590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanocidal activity of a 5-substituted 2-nitroimidazole compound (Ro 15-0216) in mice.
    Zweygarth E; Röttcher D
    Trop Med Parasitol; 1987 Sep; 38(3):171-4. PubMed ID: 3432951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
    Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
    Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel combination chemotherapy of experimental trypanosomiasis by using bleomycin and DL-alpha-difluoromethylornithine; reversal by polyamines.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Biochem Pharmacol; 1982 Sep; 31(17):2833-6. PubMed ID: 6182888
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of 2-substituted 5-nitroimidazoles in the treatment of chronic murine Trypanosoma brucei infections with central nervous system involvement.
    Jennings FW; Urquhart GM; Murray PK; Miller BM
    Z Parasitenkd; 1984; 70(6):691-7. PubMed ID: 6524019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis.
    Bacchi CJ; Berens RL; Nathan HC; Klein RS; Elegbe IA; Rao KV; McCann PP; Marr JJ
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1406-13. PubMed ID: 3118799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel drugs for human African trypanosomiasis.
    Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
    Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.